eMedicine Specialties > Pediatrics: Cardiac Disease and Critical Care Medicine > Cardiothoracic Surgery

Coarctation of the Aorta and Interrupted Aortic Arch, Surgical Treatment: Treatment

Author: Theodore C Koutlas, MD, Assistant Professor, Department of Surgery, Division of Cardiothoracic Surgery, Pitt County Memorial Hospital
Coauthor(s): David M Maziarz, MD, Fellow, Department of Surgery, Wake Forest University Baptist Medical Center; Clifton C Reade, MD, Fellow, Department of Cardiothoracic Surgery, University of Pennsylvania; Katie Love, MD, Resident Physician, Department of Surgery, Pitt County Memorial Hospital, Brody School of Medicine at East Carolina University
Contributor Information and Disclosures

Updated: Jul 21, 2009

Treatment

Medical Therapy

The role of medical therapy in coarctation is limited. Medical therapy is confined to preoperative temporization to optimize the patient's hemodynamic status before surgery.

Since 1984, medical therapy of coarctation has revolved around the introduction of prostaglandin E1 (PGE1) therapy. PGE1 allows for reopening of the ductus arteriosus and perfusion to the lower body. When PGE1 therapy is effective, the severe acidosis and oliguria, which are often present, are corrected by reestablishing blood flow to the lower body. Optimizing the patient's hemodynamic status and converting an otherwise emergency procedure into an elective one can substantially reduce the mortality risk.

For additional information, please see Coarctation of the Aorta.

Surgical Therapy

Several techniques are currently used to repair coarctation of the aorta. The method of repair is usually tailored to each patient. To help determine the operative approach, consider the length of the segment involved and whether associated anomalies are present.

Several surgical methods of repair are used, including end-to-end reanastomosis, subclavian flap aortoplasty, prosthetic patch onlay grafts, and interposition grafts (see Intraoperative details).

Many variations of the described procedures have been used throughout the years, including modification of the subclavian flap that include reimplantation, end-to-end anastomosis using the subclavian to enlarge the anastomosis, and ascending aorta–to–descending aorta bypass grafts. All of these techniques may be useful depending on the individual anatomy and associated anomalies.

The repair of associated anomalies at the time of aortic coarctation repair remains controversial. Optimal management remains unclear. If concurrent repair of associated anomalies is to be attempted at the time of coarctation repair, the best approach is by means of a median sternotomy.15 Coarctation repair is then carried out in a manner to that used to repair an interrupted aortic arch (IAA).

Current knowledge suggests ligation and division if a patent ductus is present. A bicuspid aortic valve can usually be left untreated. Strategy for concurrent ventricular septal defect (VSD) repair remains somewhat unclear. Previous studies indicated greatest survival in patients who underwent coarctation repair with pulmonary artery banding; but this has fallen out of favor due to the frequency of subsequent avoidable procedures and associated morbidities. If preoperative congestive heart failure (CHF) does not resolve, a second operation is required to close the VSD. If the VSD does spontaneously close, a debanding procedure is required.

Numerous VSDs associated with coarctation do spontaneously close, avoiding the need for cardiopulmonary bypass; this leads some to favor a 2-stage procedure. In 1992, Park et al demonstrated that this suggestion was a feasible option in 23 infants younger than 3 months, 9 of whom required no further treatment.8 Six required early closure of the VSD, and 8 required late repair. Seven more were older than 3 months, and none required repair of the VSD.

More recent reports attempt to outline predictors of spontaneous VSD closure. Considerations in decision for simultaneous VSD repair include the magnitude of the shunt through the VSD, the likelihood of persistent symptoms in the postoperative period, and whether the VSD is a type likely to spontaneously close. Initial coarctation repair is ideal when the VSD is likely to close, a band is not required, and arch hypoplasia is not present. Large size defects, defined as those with diameter greater than 50% of the aortic valve annulus, and types other than muscular such as perimembranous, inlet, outlet, and malaligned are less likely to close. 

Proximal arch hypoplasia is best addressed through a midline sternotomy to alleviate the risk of recurrent obstruction, thus a combined repair strategy is favored in this situation.16 Despite the controversy, many surgeons simply prefer to repair a clinically significant VSD when the coarctation is addressed to avoid the obvious disadvantages of the 2-stage approach.

In a retrospective analysis, Kanter et al described in detail the advantages and disadvantages of the 1-stage and 2-stage approaches and introduce the 1-stage 2-incision approach.17 All approaches have similar survival and rates of recoarctation, but the 1-stage 2-incision method results in shorter lengths of stay and corrects all defects at once without palliation and without the use of circulatory arrest or regional perfusion. The study advocates strategy selection on an individual basis.

Intraoperative Details

End-to-end reanastomosis

One of the most common methods of repair is resection of the involved segment with end-to-end reanastomosis. This repair is usually reserved for infants and small children because of the absence of enlarged collaterals and the short distance for reanastomosis. In adolescents and adults, direct anastomosis is challenging because of large collaterals and the length of the aorta necessary for adequate repair.

  • Place the patient in the right lateral decubitus position. The arterial line should be placed in the right radial artery, and a blood pressure cuff is placed on the right arm and lower extremity.
  • Make a left posterolateral thoracotomy incision.
  • Retract the lung anteriorly and inferiorly to allow for identification and incision of the pleura that overlies the descending aorta.
  • Perform careful dissection from the proximal aorta at the level of the innominate artery takeoff, to the ductus, and then as far distal as safely possible. This step includes mobilizing the intercostals arteries. The present authors prefer not to sacrifice the intercostal vessels if at all possible.
  • Avoid damage to the left recurrent laryngeal nerve, the vagus nerve, and the phrenic nerve, all which lie in the dissection field.
  • After the plane of dissection is developed, the critical component of the procedure is resection of the entire coarcted segment and ductal tissue, followed by reconstruction of the aorta without clinically significant tension on the anastomosis.
  • In general, heparin 100 units/kg is systemically administered.
  • The aorta is cross-clamped at the proximal aspect just beyond the innominate artery takeoff and at the distal aspect about 1 interspace below the coarctation. The intercostal vessels may be controlled with a vessel loop or clip.
  • The ductus is then ligated and divided if necessary. Ligating the ductus before aortic clamping creates a possibility of a ductal tear, which may be catastrophic.
  • The involved aortic segment is then resected.
  • Using a continuous absorbable monofilament suture (eg, Maxon, PDS), create the anastomosis. Release the distal aortic clamp before tying the suture to avoid "purse-stringing" of the anastomosis.
  • At the termination of the procedure, identify any residual gradient by measuring the patient's blood pressure in the lower extremity by comparing that pressure to the pressure in the right arm.
  • Transesophageal echocardiography can be useful to estimate the gradients during surgery.
  • Benefits of this particular technique include avoidance of prosthetic materials, excision of ductal tissue, preservation of the left subclavian artery, total relief of left ventricular outflow obstruction, and growth potential of the aortic anastomosis.

Subclavian-flap aortoplasty

A second commonly employed method is the subclavian-flap aortoplasty.

  • For this procedure, perform a left thoracotomy. The initial dissection follows that of the end-to-end anastomosis.
  • Identify the left subclavian and ligate it at the first branch. Ligate the vertebral artery to avoid subclavian steal.
  • Make a lengthwise incision along the coarctation, continuing on to the subclavian and creating a flap.
  • Then, resect the posterior shelf and turn down and place the subclavian flap to enlarge the constricted area, ensuring an adequate length.
  • Benefits of this technique include avoidance of prosthetic materials, decreased cross-clamp time, and the possibility that the anastomosis may grow as the child ages.

Prosthetic-patch onlay graft

First performed in 1957, this technique has fallen out of favor because of the need for prosthetic implants and the risk of aneurysms and pseudoaneurysms.18 The differential elasticity of the often-rigid grafts (historically made of Dacron) in relation to the supple aorta is believed to increase the rate of aneurysmal formation. Literature from more recent experience with homograft patch material (used extensively in arch reconstruction for hypoplastic left-heart syndrome) has not shown an increased rate of aneurysmal formation.

  • With the prosthetic patch onlay graft, perform a left thoracotomy and make a longitudinal incision along the coarcted segment.
  • In this case, do not resect the posterior shelf.
  • Sew a prosthetic patch into place, thereby enlarging the lumen.

Interposition grafts

Interposition grafts are most often used in older patients who have exceeded their growth potential. Interposition grafts are also useful when the narrowed segment cannot be completely excised without making primary reanastomosis impossible. In 1951, Gross used aortic homografts as interposition grafts and reported no clinically significant complications in 70 patients other than graft calcification, which was present in less than 50%. Aneurysmal dilatation has not been reported. The technique of interposition graft is selectively used in individuals with complex coarctation, recurrence, or aneurysmal formation.

Postoperative Details

Always measure the arm and/or leg gradient after surgery to differentiate inadequate repair from true recoarctation. In the optimal case, perform exercise testing for best accuracy because some patients do not have a gradient except during and after exercise. Although exercise testing is not a feasible option in infants and neonates, it is an excellent test for follow-up observation of adolescent patients.

Follow-up

Follow-up care of the patient with coarctation can range from an office visit with physical examination and the measurement of arm and/or leg gradients to repeat aortography to directly measure any residual gradients and to identify any anatomic problems.

With the advent of advanced echocardiography, physicians are increasingly willing to rely on the noninvasive results obtained with this technique. Echocardiography can enable a good approximation of the anatomy, and it provides a good estimation of gradients.

Causes implicated in recoarctation include inadequate resection of ductal tissue, failure of anastomotic growth, and suture-line thrombosis.

Complications

Given the technical complexity of coarctation repair, the list of complications is remarkably short. Many of the complications are not specific to coarctation but are common with other cardiac procedures; these include hemorrhage, infection, chylothorax (from injuries to the thoracic duct), suture line thrombosis, and suboptimal repair or recurrence.

Numerous complications are unique to both aortic surgery and coarctation. A 2-phased phenomenon of paradoxic hypertension can occur after coarctation repair. During the first phase, systolic blood pressure rises throughout the first 24-36 hours after the operation. This rise is believed to result from activation of the sympathetic nervous system with elevation of serum catecholamine levels. A rise in diastolic blood pressure occurs later and is a result of activation of the renin-angiotensin system.

Another complication unique to coarctation repair is the postcoarctectomy syndrome of abdominal pain and distension that Sealy first described in 1957. As many as 20% of patients have this complication, and laparotomy may be necessary. In 1985, Kawauchi et al noted that mesenteric ischemia secondary to acute necrotizing arteritis appeared to be the cause.19 Recent data suggest that aggressive control of postoperative hypertension usually prevents the full-blown syndrome. In addition, this phenomenon appears to be associated with coarctation in older patients, as this complication is rarely seen with infants and small children.

The most worrisome complication after coarctation repair continues to be paraplegia, which occurring in 0.1-1% of neonates after coarctation repair. No definitive predisposing factors are known. Current data suggest that poor collaterals, anomalies of the origin of the right subclavian artery, distal hypertension during cross-clamp, reoperation, or relative hyperthermia during the operation may all contribute to the incidence of paraplegia. The incidence in the adult population undergoing coarctation repair rises proportionately with age and is as high as 2.6%.

The tremendous variation in spinal-cord blood supply, including the elusive artery of Adamkiewicz, makes predicting adequate collateral flow extraordinarily difficult. Some theories suggest that maintaining a distal aortic pressure of more than 60 mm Hg may help to prevent cord ischemia (as measured by means of maintenance of somatosensory evoked potentials), and some have suggested using a shunt to achieve this if necessary. In 1987, Cunningham demonstrated that distal hypertension with loss of somatosensory evoked potentials for more than 30 minutes resulted in a more than 70% incidence of paraplegia.20

Other complications include temporary or permanent hoarseness from recurrent injury to the laryngeal nerve. The nerve can be directly injured by transection or indirectly by retraction. Careful identification of the anatomy and knowledge of the course of the recurrent laryngeal nerve is critical to avoid this complication.

More on Coarctation of the Aorta and Interrupted Aortic Arch, Surgical Treatment

Overview: Coarctation of the Aorta and Interrupted Aortic Arch, Surgical Treatment
Workup: Coarctation of the Aorta and Interrupted Aortic Arch, Surgical Treatment
Treatment: Coarctation of the Aorta and Interrupted Aortic Arch, Surgical Treatment
Follow-up: Coarctation of the Aorta and Interrupted Aortic Arch, Surgical Treatment
Multimedia: Coarctation of the Aorta and Interrupted Aortic Arch, Surgical Treatment
References

References

  1. Schreiber C, Mazzitelli D, Haehnel JC, et al. The interrupted aortic arch: an overview after 20 years of surgical treatment. Eur J Cardiothorac Surg. Sep 1997;12(3):466-9; discussion 469-70. [Medline].

  2. Celoria GC, Patton RB. Congenital absence of the aortic arch. Am Heart J. 1959;58:408.

  3. Brown JW, Ruzmetov M, Okada Y, Vijay P, Rodefeld MD, Turrentine MW. Outcomes in patients with interrupted aortic arch and associated anomalies: a 20-year experience. Eur J Cardiothorac Surg. May 2006;29(5):666-73; discussion 673-4. [Medline].

  4. Shen I, Ungerleider RM; Ohye RG, Suzuki T, Devaney EJ, Bove EL. Coarctation of the Aorta, Interrupted Aortic Arch Complex. In: Kaiser LR, Kron IL, Spray TL. Mastery of Cardiothoracic Surgery. Second. Philadelphia, PA: Lippincott, Williams and Wilkins; 2007:chap 78-79.

  5. Grech V. Diagnostic and surgical trends, and epidemiology of coarctation of the aorta in a population-based study. Int J Cardiol. Feb 28 1999;68(2):197-202. [Medline].

  6. Van Son JA, Mohr FW, Hess H, et al. Early repair of coarctation of the aorta. Ann Thorac Cardiovasc Surg. Aug 1999;5(4):237-44. [Medline].

  7. Moene RJ, Gittenberger-de Groot AC, Oppenheimer-Dekker A, Bartelings MM. Anatomic characteristics of ventricular septal defect associated with coarctation of the aorta. Am J Cardiol. Apr 15 1987;59(9):952-5. [Medline].

  8. Park JK, Dell RB, Ellis K, Gersony WM. Surgical management of the infant with coarctation of the aorta and ventricular septal defect. J Am Coll Cardiol. Jul 1992;20(1):176-80. [Medline].

  9. Parr GV, Waldhausen JA, Bharati S, et al. Coarctation in Taussig-Bing malformation of the heart. Surgical significance. J Thorac Cardiovasc Surg. Aug 1983;86(2):280-7. [Medline].

  10. Sadow SH, Synhorst DP, Pappas G. Taussig-Bing anomaly and coarctation of the aorta in infancy: surgical options. Pediatr Cardiol. 1985;6(2):83-9. [Medline].

  11. Campbell M. Natural history of coarctation of the aorta. Br Heart J. Sep 1970;32(5):633-40. [Medline].

  12. Shearer WT, Rutman JY, Weinberg WA, Goldring D. Coarctation of the aorta and cerebrovascular accident: a proposal for early corrective surgery. J Pediatr. Dec 1970;77(6):1004-9. [Medline].

  13. Kpodonu J, Ramaiah VG, Diethrich EB. Intravascular ultrasound imaging as applied to the aorta: a new tool for the cardiovascular surgeon. Ann Thorac Surg. Oct 2008;86(4):1391-8. [Medline].

  14. Rudolph AM, Heymann MA, Spitznas U. Hemodynamic considerations in the development of narrowing of the aorta. Am J Cardiol. Oct 1972;30(5):514-25. [Medline].

  15. Ungerleider RM, Ebert PA. Indications and techniques for midline approach to aortic coarctation in infants and children. Ann Thorac Surg. Nov 1987;44(5):517-22. [Medline].

  16. Alsoufi B, Cai S, Coles JG, Williams WG, Van Arsdell GS, Caldarone CA. Outcomes of different surgical strategies in the treatment of neonates with aortic coarctation and associated ventricular septal defects. Ann Thorac Surg. Oct 2007;84(4):1331-6; discussion 1336-7. [Medline].

  17. Kanter KR, Mahle WT, Kogon BE, Kirshbom PM. What is the optimal management of infants with coarctation and ventricular septal defect?. Ann Thorac Surg. Aug 2007;84(2):612-8; discussion 618. [Medline].

  18. Aebert H, Laas J, Bednarski P, et al. High incidence of aneurysm formation following patch plasty repair of coarctation. Eur J Cardiothorac Surg. 1993;7(4):200-4; discussion 205. [Medline].

  19. Kawauchi M, Tada Y, Asano K, Sudo K. Angiographic demonstration of mesenteric arterial changes in postcoarctectomy syndrome. Surgery. Sep 1985;98(3):602-4. [Medline].

  20. Cunningham JN Jr, Laschinger JC, Spencer FC. Monitoring of somatosensory evoked potentials during surgical procedures on the thoracoabdominal aorta. IV. Clinical observations and results. J Thorac Cardiovasc Surg. Aug 1987;94(2):275-85. [Medline].

  21. Seirafi PA, Warner KG, Geggel RL, et al. Repair of coarctation of the aorta during infancy minimizes the risk of late hypertension. Ann Thorac Surg. Oct 1998;66(4):1378-82. [Medline].

  22. Backer CL, Mavroudis C, Zias EA, et al. Repair of coarctation with resection and extended end-to-end anastomosis. Ann Thorac Surg. Oct 1998;66(4):1365-70; discussion 1370-1. [Medline].

  23. Allen BS, Halldorsson AO, Barth MJ, Ilbawi MN. Modification of the subclavian patch aortoplasty for repair of aortic coarctation in neonates and infants. Ann Thorac Surg. Mar 2000;69(3):877-80; discussion 881. [Medline].

  24. Sciolaro C, Copeland J, Cork R, et al. Long-term follow-up comparing subclavian flap angioplasty to resection with modified oblique end-to-end anastomosis. J Thorac Cardiovasc Surg. Jan 1991;101(1):1-13. [Medline].

  25. Fiore AC, Fischer LK, Schwartz T, et al. Comparison of angioplasty and surgery for neonatal aortic coarctation. Ann Thorac Surg. Nov 2005;80(5):1659-64; discussion 1664-5. [Medline].

  26. Cowley CG, Orsmond GS, Feola P, et al. Long-term, randomized comparison of balloon angioplasty and surgery for native coarctation of the aorta in childhood. Circulation. Jun 28 2005;111(25):3453-6. [Medline].

  27. Karl TR. Surgery is the best treatment for primary coarctation in the majority of cases. J Cardiovasc Med (Hagerstown). Jan 2007;8(1):50-6. [Medline].

  28. Al-Ata J, Arfi AM, Hussain A, Kouatly A, Galal MO. Stent angioplasty: an effective alternative in selected infants with critical native aortic coarctation. Pediatr Cardiol. May-Jun 2007;28(3):183-92. [Medline].

  29. Marshall AC, Perry SB, Keane JF, Lock JE. Early results and medium-term follow-up of stent implantation for mild residual or recurrent aortic coarctation. Am Heart J. Jun 2000;139(6):1054-60. [Medline].

  30. Thanopoulos BD, Hadjinikolaou L, Konstadopoulou GN, et al. Stent treatment for coarctation of the aorta: intermediate term follow up and technical considerations. Heart. Jul 2000;84(1):65-70. [Medline].

  31. Kutty S, Greenberg RK, Fletcher S, Svensson LG, Latson LA. Endovascular stent grafts for large thoracic aneurysms after coarctation repair. Ann Thorac Surg. Apr 2008;85(4):1332-8. [Medline].

  32. Abbott ME. Coarctation of the aorta of the adult type. Am. Heart J. 1928;3:574.

  33. Aeba R, Katogi T, Ueda T, et al. Complications following reparative surgery for aortic coarctation or interrupted aortic arch. Surg Today. 1998;28(9):889-94. [Medline].

  34. Bogers AJ, Contant CM, Hokken RB, Cromme-Dijkhuis AH. Repair of aortic arch interruption by direct anastomosis. Eur J Cardiothorac Surg. Jan 1997;11(1):100-4. [Medline].

  35. DeLeon MM, DeLeon SY, Quinones JA, et al. Management of arch hypoplasia after successful coarctation repair. Ann Thorac Surg. Apr 1997;63(4):975-80. [Medline].

  36. Hirooka K, Fraser CD Jr. One-stage neonatal repair of complex aortic arch obstruction or interruption. Recent experience at Texas Children's Hospital. Tex Heart Inst J. 1997;24(4):317-21. [Medline].

  37. Jahangiri M, Shinebourne EA, Zurakowski D, et al. Subclavian flap angioplasty: does the arch look after itself?. J Thorac Cardiovasc Surg. Aug 2000;120(2):224-9. [Medline].

  38. Jenkins NP, Ward C. Coarctation of the aorta: natural history and outcome after surgical treatment. QJM. Jul 1999;92(7):365-71. [Medline].

  39. Jimenez M, Daret D, Choussat A, Bonnet J. Immunohistological and ultrastructural analysis of the intimal thickening in coarctation of human aorta. Cardiovasc Res. Mar 1999;41(3):737-45. [Medline].

  40. Mainwaring RD, Lamberti JJ. Mid- to long-term results of the two-stage approach for type B interrupted aortic arch and ventricular septal defect. Ann Thorac Surg. Dec 1997;64(6):1782-5; discussion 1785-6. [Medline].

  41. O'Connor AR, Moody AR, Ludman CN. Images in cardiology. Aortic coarctation diagnosed by magnetic resonance angiography. Heart. Jun 1999;81(6):671. [Medline].

  42. Ovaert C, McCrindle BW, Nykanen D, et al. Balloon angioplasty of native coarctation: clinical outcomes and predictors of success. J Am Coll Cardiol. Mar 15 2000;35(4):988-96. [Medline].

  43. Reifenstein GH, Levine SA, Gross RE. Coarctation of the aorta: a review of 104 autopsied cases of the "adult type" 2 years of age or older. Am Heart J. 1947;33:146.

  44. Rothman A. Coarctation of the aorta: an update. Curr Probl Pediatr. Feb 1998;28(2):33-60. [Medline].

  45. Saba SE, Nimri M, Shamaileh Q, et al. Balloon coarctation angioplasty: follow-up of 103 patients. J Invasive Cardiol. Aug 2000;12(8):402-6. [Medline].

  46. Sakopoulos AG, Hahn TL, Turrentine M, Brown JW. Recurrent aortic coarctation: is surgical repair still the gold standard?. J Thorac Cardiovasc Surg. Oct 1998;116(4):560-5. [Medline].

  47. Thanopoulos BV, Eleftherakis N, Tzanos K, Skoularigis I, Triposkiadis F. Stent implantation for adult aortic coarctation. J Am Coll Cardiol. Nov 25 2008;52(22):1815-6. [Medline].

  48. Tlaskal T, Hucin B, Hruda J, et al. Results of primary and two-stage repair of interrupted aortic arch. Eur J Cardiothorac Surg. Sep 1998;14(3):235-42. [Medline].

  49. Vitullo DA, DeLeon SY, Graham LC, et al. Extended end-to-end repair and enlargement of the entire arch in complex coarctation. Ann Thorac Surg. Feb 1999;67(2):528-31. [Medline].

  50. Wong CH, Watson B, Smith J. The use of left heart bypass in adult and recurrent coarctation repair. Eur J Cardiothorac Surg. Dec 2001;20(6):1199-201. [Medline].

  51. Wood MK. Acyanotic cardiac lesions with normal pulmonary blood flow. Neonatal Netw. Apr 1998;17(3):5-11. [Medline].

Further Reading

Keywords

coarctation of the aorta and interrupted aortic arch, CoA, coarctation tubular hypoplasia, IAA, interrupted aortic arch, infantile coarctation, adult coarctation, preductal coarctation, postductal coarctation, juxtaductal coarctation, recoarctation, tubular hypoplasia, pseudocoarctation, DiGeorge syndrome, DiGeorge's syndrome, ventricular septal defect, VSD, Turner syndrome, Turner's syndrome, aortopulmonary window, left ventricular outflow tract obstruction, double-outlet right ventricle, truncus arteriosus, bicuspid aortic valve, hypertension, treatment, diagnosis

Contributor Information and Disclosures

Author

Theodore C Koutlas, MD, Assistant Professor, Department of Surgery, Division of Cardiothoracic Surgery, Pitt County Memorial Hospital
Theodore C Koutlas, MD is a member of the following medical societies: American College of Surgeons, Society of Thoracic Surgeons, and Southern Thoracic Surgical Association
Disclosure: Nothing to disclose.

Coauthor(s)

David M Maziarz, MD, Fellow, Department of Surgery, Wake Forest University Baptist Medical Center
David M Maziarz, MD is a member of the following medical societies: American College of Surgeons
Disclosure: Nothing to disclose.

Clifton C Reade, MD, Fellow, Department of Cardiothoracic Surgery, University of Pennsylvania
Clifton C Reade, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, Society of Thoracic Surgeons, and Southeastern Surgical Congress
Disclosure: Nothing to disclose.

Katie Love, MD, Resident Physician, Department of Surgery, Pitt County Memorial Hospital, Brody School of Medicine at East Carolina University
Katie Love, MD is a member of the following medical societies: American College of Surgeons
Disclosure: Nothing to disclose.

Medical Editor

Daniel S Schwartz, MD, FACS, Assistant Clinical Professor of Cardiothoracic Surgery, Mount Sinai School of Medicine; Chief of Thoracic Surgery, Huntington Hospital
Daniel S Schwartz, MD, FACS is a member of the following medical societies: American College of Chest Physicians, American College of Surgeons, Society of Thoracic Surgeons, and Western Thoracic Surgical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Mary C Mancini, MD, PhD, Professor, Department of Surgery, Louisiana State University Health Sciences Center
Mary C Mancini, MD, PhD is a member of the following medical societies: American Association for Thoracic Surgery, American College of Surgeons, American Surgical Association, Phi Beta Kappa, Society of Thoracic Surgeons, and Southern Surgical Association
Disclosure: Nothing to disclose.

CME Editor

Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine
Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine
Disclosure: Baxter Honoraria Consulting

Chief Editor

John Kupferschmid, MD, Director of Congenital Heart Surgery, Department of Surgery, Methodist Children's Hospital at San Antonio
John Kupferschmid, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Surgeons, Society of Thoracic Surgeons, and Society of Thoracic Surgeons
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.